Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Exclusives

More »

For full access to this article login to GEN Select now.

Apr 16, 2014

NIH's NINDS Gets Back to Research Basics

Institute vows to roll back growth in applied grant funding.

NIH's NINDS Gets Back to Research Basics

NINDS has shifted much of its research spending from basic research to applied research over the past seventeen years. [© Dani Simmonds - Fotolia.com]

  • NIH’s National Institute of Neurological Disorders and Stroke (NINDS) is promising to get serious about reversing its sharp decline in basic research funding since ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.
    •  


Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »